Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== I-BRD9 4μM R07 exp365 ====== ==== Mechanism of Action ==== Inhibits BRD9 subunit of SWI/SNF complex * **<color #00a2e8>Class / Subclass 1:</color>** Gene Regulation / Epigenetic Inhibitor ==== Technical Notes ==== <accordion collapsed='true'> <panel title='Compound References' collapsed='true'> * **<color #00a2e8>PubChem Name:</color>** %%N'-(1,1-Dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide%% * **<color #00a2e8>Synonyms:</color>** N/A * **<color #00a2e8>CAS #:</color>** 1714146-59-4 * **<color #00a2e8>PubChem CID:</color>** [[https://pubchem.ncbi.nlm.nih.gov/compound/91668541|91668541]] * **<color #00a2e8>IUPAC:</color>** %%N'-(1,1-dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide%% * **<color #00a2e8>INCHI Name:</color>** InChI=1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27) * **<color #00a2e8>INCHI Key:</color>** WRUWGLUCNBMGPS-UHFFFAOYSA-N * **<color #00a2e8>Molecular Weight:</color>** 497.6 * **<color #00a2e8>Canonical SMILES:</color>** CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F * **<color #00a2e8>Isomeric SMILES:</color>** N/A * **<color #00a2e8>Molecular Formula:</color>** C22H22F3N3O3S2 {{:chemogenomics:structures:chem-0216.svg?nolink}} </panel> <panel title='Compound Supplier' collapsed='true'> * **<color #00a2e8>Supplier Name:</color>** Tocris Bioscience * **<color #00a2e8>Catalog #:</color>** 5591 * **<color #00a2e8>Lot #:</color>** N/A </panel> <panel title='Compound Characterization' collapsed='true'> * **<color #00a2e8>HRMS (ESI-TOF) m/z:</color>** (M+H)+ Calcd for C22H22F3N3O3S2 498.11274; found 498.11359 </panel> <panel title='Dose Response Curve' collapsed='true'> * **<color #00a2e8>Platform ID:</color>** I-BRD9 * **<color #00a2e8>Min:</color>** -3.1583; **<color #00a2e8>Max:</color>** 99.2289 {{:chemogenomics:dose_response:dr_433.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |2.1168 | | IC30 |3.0470 | | IC40 |4.1521 | | IC50 |5.5496 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ </panel> </accordion> ==== Screen Summary ==== * **<color #00a2e8>Round</color>**: 07 * **<color #00a2e8>Dose</color>**: 4µM * **<color #00a2e8>Days of incubation</color>**: 8 * **<color #00a2e8>Doublings</color>**: 1.8 * **<color #00a2e8>Numbers of reads</color>**: 14995463 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |12/88|<color #e85500>[[https://files.tyerslab.com/files/public/chemogenomics/cranks/I-BRD9_4uM_Round-7_exp365.txt|Scores]]</color>|<button type="primary" size="sm" modal="ScorePlot">View</button>|<button type="primary" size="sm" modal="modal_hits">View</button>|<button type="primary" size="sm" modal="modal_screen_similarity">View</button>|<button type="default" size="sm" modal="modal_go_sensitive">View</button>|<button type="primary" size="sm" modal="modal_go_resistant">View</button>| <modal id='ScorePlot' size='lg' title='I-BRD9 4μM R07 exp365'> {{:chemogenomics:cranks_plots:exp365.png?nolink}} </modal> <modal id="modal_hits" size="sm" title="Top 30 S/R Genes"> ^Gene^CRANKS Score^FDR^ |[[:human_genes:G:GNAS|GNAS]]|-3.81|<0.01| |[[:human_genes:T:TCF4|TCF4]]|-3.66|<0.01| |[[:human_genes:Y:YRDC|YRDC]]|-3.27|<0.01| |[[:human_genes:S:SLC5A3|SLC5A3]]|-3.00|<0.01| |[[:human_genes:I:ITFG2|ITFG2]]|-2.91|<0.01| |[[:human_genes:E:ELAVL1|ELAVL1]]|-2.84|<0.01| |[[:human_genes:G:GTF2H5|GTF2H5]]|-2.79|<0.01| |[[:human_genes:A:ARL1|ARL1]]|-2.74|0.01| |[[:human_genes:Z:ZBTB10|ZBTB10]]|-2.70|0.01| |[[:human_genes:S:STAG2|STAG2]]|-2.68|0.01| |[[:human_genes:X:XPOT|XPOT]]|-2.58|0.02| |[[:human_genes:S:SPEN|SPEN]]|-2.51|0.03| |[[:human_genes:M:MSL1|MSL1]]|-2.43|0.08| |[[:human_genes:M:MSI2|MSI2]]|-2.43|0.08| |[[:human_genes:F:FLI1|FLI1]]|-2.42|0.08| |[[:human_genes:N:NRAS|NRAS]]|-2.40|0.08| |[[:human_genes:C:CPSF7|CPSF7]]|-2.35|0.07| |[[:human_genes:Z:ZBTB5|ZBTB5]]|-2.34|0.07| |[[:human_genes:P:PRKACA|PRKACA]]|-2.33|0.07| |[[:human_genes:B:BRD2|BRD2]]|-2.33|0.10| |[[:human_genes:N:NBPF12|NBPF12]]|-2.30|0.47| |[[:human_genes:B:BACH2|BACH2]]|-2.27|0.11| |[[:human_genes:Z:ZNF319|ZNF319]]|-2.26|0.08| |[[:human_genes:T:TINF2|TINF2]]|-2.22|0.13| |[[:human_genes:T:TSPY2|TSPY2]]|-2.21|0.17| |[[:human_genes:P:PDAP1|PDAP1]]|-2.21|0.10| |[[:human_genes:G:GPATCH8|GPATCH8]]|-2.21|0.10| |[[:human_genes:P:PDCL|PDCL]]|-2.20|0.10| |[[:human_genes:P:PIAS4|PIAS4]]|-2.19|0.14| |[[:human_genes:P:PCIF1|PCIF1]]|-2.17|0.10| |[[:human_genes:R:RBM10|RBM10]]|3.05|0.00| |[[:human_genes:R:RFWD2|RFWD2]]|3.11|0.00| |[[:human_genes:R:RFX7|RFX7]]|3.14|0.00| |[[:human_genes:P:PRR14L|PRR14L]]|3.14|0.00| |[[:human_genes:P:PHF14|PHF14]]|3.21|0.00| |[[:human_genes:M:MEMO1|MEMO1]]|3.25|0.00| |[[:human_genes:S:SMARCC1|SMARCC1]]|3.31|0.00| |[[:human_genes:R:RBM38|RBM38]]|3.31|0.00| |[[:human_genes:N:NAA15|NAA15]]|3.32|0.00| |[[:human_genes:A:AXIN1|AXIN1]]|3.35|0.00| |[[:human_genes:T:TSC22D2|TSC22D2]]|3.38|0.00| |[[:human_genes:S:SNRPA|SNRPA]]|3.42|0.00| |[[:human_genes:E:EIF4ENIF1|EIF4ENIF1]]|3.45|0.00| |[[:human_genes:A:ARID1A|ARID1A]]|3.56|0.00| |[[:human_genes:S:SETD1A|SETD1A]]|3.59|0.00| |[[:human_genes:Y:YLPM1|YLPM1]]|3.67|0.00| |[[:human_genes:F:FKBPL|FKBPL]]|3.70|0.00| |[[:human_genes:B:BTG2|BTG2]]|3.85|0.00| |[[:human_genes:C:CBLL1|CBLL1]]|3.90|0.00| |[[:human_genes:C:CCNK|CCNK]]|4.15|0.00| |[[:human_genes:C:CDK13|CDK13]]|4.39|0.00| |[[:human_genes:F:FAM58A|FAM58A]]|4.40|0.00| |[[:human_genes:H:HNRNPH1|HNRNPH1]]|4.46|0.00| |[[:human_genes:U:UBE2H|UBE2H]]|4.50|0.00| |[[:human_genes:R:RPRD1B|RPRD1B]]|4.62|0.00| |[[:human_genes:S:SPOP|SPOP]]|4.69|0.00| |[[:human_genes:R:RB1|RB1]]|4.92|0.00| |[[:human_genes:C:CNOT8|CNOT8]]|4.96|0.00| |[[:human_genes:F:FAM122A|FAM122A]]|5.59|0.00| |[[:human_genes:T:TTC14|TTC14]]|5.82|0.00| </modal> <modal id="modal_screen_similarity" size="lg" title="Correlated Screens"> ^Screen^Correlation^Plot^ |[[:results:exp306|Rapamycin 2μM R07 exp306]]|0.071|<button type="primary" size="small" modal="1">View</button>| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|0.07|<button type="primary" size="small" modal="2">View</button>| |[[:results:exp504|MK2206 4μM R08 exp504]]|0.059|<button type="primary" size="small" modal="3">View</button>| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|0.054|<button type="primary" size="small" modal="4">View</button>| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.053|<button type="primary" size="small" modal="5">View</button>| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|0.051|<button type="primary" size="small" modal="6">View</button>| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|0.051|<button type="primary" size="small" modal="7">View</button>| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|0.051|<button type="primary" size="small" modal="8">View</button>| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.063|<button type="primary" size="small" modal="9">View</button>| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|0.062|<button type="primary" size="small" modal="10">View</button>| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|0.061|<button type="primary" size="small" modal="11">View</button>| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|0.054|<button type="primary" size="small" modal="12">View</button>| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|0.051|<button type="primary" size="small" modal="13">View</button>| </modal> <modal id="1" size="lg" title="I-BRD9 4μM R07 exp365 vs Rapamycin 2μM R07 exp306"> {{:chemogenomics:comparison_plots:exp306_vs_exp365.png?nolink |}} </modal> <modal id="2" size="lg" title="I-BRD9 4μM R07 exp365 vs Lead acetate 2000μM R08 exp497"> {{:chemogenomics:comparison_plots:exp365_vs_exp497.png?nolink |}} </modal> <modal id="3" size="lg" title="I-BRD9 4μM R07 exp365 vs MK2206 4μM R08 exp504"> {{:chemogenomics:comparison_plots:exp365_vs_exp504.png?nolink |}} </modal> <modal id="4" size="lg" title="I-BRD9 4μM R07 exp365 vs LY2090314 0.003μM R08 exp499"> {{:chemogenomics:comparison_plots:exp365_vs_exp499.png?nolink |}} </modal> <modal id="5" size="lg" title="I-BRD9 4μM R07 exp365 vs LY2090314 0.003μM R08 exp500 no dilution day6"> {{:chemogenomics:comparison_plots:exp365_vs_exp500.png?nolink |}} </modal> <modal id="6" size="lg" title="I-BRD9 4μM R07 exp365 vs Lead acetate 2000μM R08 exp498 no dilution day6"> {{:chemogenomics:comparison_plots:exp365_vs_exp498.png?nolink |}} </modal> <modal id="7" size="lg" title="I-BRD9 4μM R07 exp365 vs TRAIL 50ng/ml R00 exp36"> {{:chemogenomics:comparison_plots:exp36_vs_exp365.png?nolink |}} </modal> <modal id="8" size="lg" title="I-BRD9 4μM R07 exp365 vs Tubacin 1.6μM R07 exp416"> {{:chemogenomics:comparison_plots:exp365_vs_exp416.png?nolink |}} </modal> <modal id="9" size="lg" title="GSK626616 14μM R08 exp485 vs I-BRD9 4μM R07 exp365"> {{:chemogenomics:comparison_plots:exp365_vs_exp485.png?nolink |}} </modal> <modal id="10" size="lg" title="Dexamethasone 0.006 to 0.015μM on day4 R07 exp352 vs I-BRD9 4μM R07 exp365"> {{:chemogenomics:comparison_plots:exp352_vs_exp365.png?nolink |}} </modal> <modal id="11" size="lg" title="Dimethyl-Sulfoxide 1pc R03 exp120 vs I-BRD9 4μM R07 exp365"> {{:chemogenomics:comparison_plots:exp120_vs_exp365.png?nolink |}} </modal> <modal id="12" size="lg" title="BI-D1870 2μM R04 exp162 vs I-BRD9 4μM R07 exp365"> {{:chemogenomics:comparison_plots:exp162_vs_exp365.png?nolink |}} </modal> <modal id="13" size="lg" title="BI-D1870 3.15μM R02 exp66 vs I-BRD9 4μM R07 exp365"> {{:chemogenomics:comparison_plots:exp365_vs_exp66.png?nolink |}} </modal> <modal id="modal_go_sensitive" size="lg" title="Top 30 sensitive GO terms">No GO term hits below threshold. (FDR <0.05)</modal> <modal id="modal_go_resistant" size="lg" title="Top 30 resistant GO terms"> ^GO Term^Fold Change^Genes^ |RNA polymerase II CTD heptapeptide repeat kinase activity|184.21|CDK13,CCNK,CDK8| |nuclear cyclin-dependent protein kinase holoenzyme complex|118.42|CDK13,CCNK,CDK8| |RNA polymerase II CTD heptapeptide repeat modifying activity|97.52|CDK13,CCNK,CDK8| |cyclin-dependent protein kinase activity|59.21|CDK13,CCNK,CDK8| |cyclin-dependent protein serine/threonine kinase activity|59.21|CDK13,CCNK,CDK8| |SWI/SNF complex|57.17|RB1,ARID1A,SMARCC1| |cyclin-dependent protein kinase holoenzyme complex|41.71|CCNQ,CDK13,CCNK,CDK8| |serine/threonine protein kinase complex|21.93|CCNQ,CDK13,CCNK,CDK8,TGFBR2| |protein kinase complex|18.93|CCNQ,CDK13,CCNK,CDK8,TGFBR2| |nuclear speck|12.22|SPOP,CDK13,CBLL1,YLPM1,SETD1A,EIF4ENIF1,COP1,RBM10,ZNF217| |mRNA metabolic process|7.52|CNOT8,RPRD1B,HNRNPH1,CDK13,CBLL1,SNRPA,RBM38,RBM10| |nuclear body|7.48|RB1,SPOP,CDK13,CBLL1,YLPM1,SETD1A,EIF4ENIF1,NAA15,COP1,RBM10,ZNF217| |transferase complex|6.67|SPOP,CCNQ,CDK13,CCNK,CBLL1,SETD1A,NAA15,COP1,CDK8,TGFBR2| </modal> Last modified: 2026/01/15 21:36by 127.0.0.1